Novo Nordisk A/S (NVO)

45.76 +0.89 (+1.98%) USD  |  NYSE  |  May 06, 16:00
46.30 +0.54 (+1.18%) Pre-Market: 04:55
More

Novo Nordisk Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Evaxion AS Upgrade
Ascendis Pharma A/S Upgrade
Prothena Corp. Plc Upgrade
Viking Therapeutics, Inc. Upgrade
Cellectis SA Upgrade